Abstract
Mucosal melanoma is a rare subtype of melanoma that accounts for 1% of all melanomas. The incidence of nasal mucosal melanomas is 0.3 per million. Desmoplastic melanomas are a subtype of melanoma with a reported incidence of 2.0 per million. Although 50% of desmoplastic melanomas are found in the head and neck region, mucosal desmoplastic melanoma is exceedingly rare. In the present study, we report a case of nasal mucosal desmoplastic melanoma and review the literature. A 79-year-old female presented to an outside otolaryngologist with nasal discomfort accompanied by rhinorrhea and was found to have a nasal vestibule mass. An endonasal incisional biopsy was performed yielding a diagnosis of a SOX-10 positive tumor. The patient was referred to our institution for further management. A blue-tinged lesion was identified at the prior biopsy site, and the mass was resected via an open rhinoplasty approach. Final pathology demonstrated an infiltrative spindle cell neoplasm with immunohistochemical patterns supportive of desmoplastic melanoma arising from the nasal vestibule. Due to positive margins, the patient underwent a re-resection with no tumor identified on the re-resected specimen. To our knowledge, this is the third case of nasal mucosal desmoplastic melanoma. We review the clinicopathologic features and management of this rare entity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of Data and Material
Not applicable.
References
Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer. 1971;28(4):914–36. https://doi.org/10.1002/1097-0142(1971)28:4.
Feng Z, Wu X, Chen V, Velie E, Zhang Z. Incidence and survival of desmoplastic melanoma in the United States, 1992-2007. J Cutan Pathol. 2011;38(8):616–24. https://doi.org/10.1111/j.1600-0560.2011.01704.x.
Prasad ML, Patel SG, Busam KJ. Primary mucosal desmoplastic melanoma of the head and neck. Head Neck. 2004;26(4):373–7. https://doi.org/10.1002/hed.10384.
Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol. 2005;152(4):673–8. https://doi.org/10.1111/j.1365-2133.2005.06462.x.
Cervantes SS, Baugh R. Primary mucosal desmoplastic melanoma of the nasal vestibule: the second case. Ear Nose Throat J. 2011;90(10):483–5. https://doi.org/10.1177/014556131109001008.
Min SK, Jeong JH, Ahn KM, Yoo CW, Park JY, Choi SW. Desmoplastic melanoma of the oral cavity: diagnostic pitfalls and clinical characteristics. J Korean Assoc Oral Maxillofac Surg. 2018;44(2):66–72. https://doi.org/10.5125/jkaoms.2018.44.2.66.
Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer. 1997;80(8):1373–86. https://doi.org/10.1002/(sici)1097-0142(19971015)80:8.
Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol. 2012;5(8):739–53.
Magro CM, Crowson AN, Mihm MC. Unusual variants of malignant melanoma. Mod Pathol. 2006;19(Suppl 2):41–70. https://doi.org/10.1038/modpathol.3800516.
Wharton JM, Carlson JA, Mihm MC Jr. Desmoplastic malignant melanoma: diagnosis of early clinical lesions. Hum Pathol. 1999;30(5):537–42. https://doi.org/10.1016/s0046-8177(99)90198-3.
Saliba E, Bhawan J. Aberrant Expression of Immunohistochemical Markers in Malignant Melanoma: A Review. Dermatopathol (Basel). 2021;8(3):359–70. https://doi.org/10.3390/dermatopathology8030040.
Plaza JA, Bonneau P, Prieto V, Sangueza M, Mackinnon A, Suster D, et al. Desmoplastic melanoma: an updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis. J Cutan Pathol. 2016;43(4):313–23. https://doi.org/10.1111/cup.12654.
Prieto-Granada CN, Wiesner T, Messina JL, Jungbluth AA, Chi P, Antonescu CR. Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST. Am J Surg Pathol. 2016;40(4):479–89. https://doi.org/10.1097/PAS.0000000000000564.
Scolyer RA, Thompson JF. Desmoplastic melanoma: a heterogeneous entity in which subclassification as “pure” or “mixed” may have important prognostic significance. Ann Surg Oncol. 2005;12(3):197–9. https://doi.org/10.1245/ASO.2005.12.914.
George E, McClain SE, Slingluff CL, Polissar NL, Patterson JW. Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis. J Cutan Pathol. 2009;36(4):425–32. https://doi.org/10.1111/j.1600-0560.2008.01058.x.
Chen LL, Jaimes N, Barker CA, Busam KJ, Marghoob AA. Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68(5):825–33. https://doi.org/10.1016/j.jaad.2012.10.041.
Hughes TM, Williams GJ, Gyorki DE, Kelly JW, Stretch JR, Varey AHR, et al. Desmoplastic melanoma: a review of its pathology and clinical behaviour, and of management recommendations in published guidelines. J Eur Acad Dermatol Venereol. 2021;35(6):1290–8. https://doi.org/10.1111/jdv.17154.
Oliver DE, Patel KR, Switchenko J, Parker D, Lawson DH, Delman KA, et al. Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma Res. 2016;26(1):35–41. https://doi.org/10.1097/CMR.0000000000000201.
Jaroszewski DE, Pockaj BA, DiCaudo DJ, Bite U. The clinical behavior of desmoplastic melanoma. Am J Surg. 2001;182(6):590–5. https://doi.org/10.1016/s0002-9610(01)00819-4.
Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664–78. https://doi.org/10.1002/(sici)1097-0142(19981015)83:8.
Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol. 2017;112:136–52. https://doi.org/10.1016/j.critrevonc.2017.01.019.
Rule WG, Allred JB, Pockaj BA, Markovic SN, DiCaudo DJ, Erickson LA, et al. Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma. Cancer Med. 2016;5(8):1890–6. https://doi.org/10.1002/cam4.783.
Abbott JL, Qureshi MM, Truong MT, Sahni D. Comparing survival outcomes in early stage desmoplastic melanoma with or without adjuvant radiation. Melanoma Res. 2019;29(4):413–9. https://doi.org/10.1097/CMR.0000000000000532.
Eroglu Z, Zaretsky JM, Hu-Lieskovan S, Kim DW, Algazi A, Johnson DB, et al. High response rate to PD-1 blockade in desmoplastic melanomas. Nature. 2018;553(7688):347–50. https://doi.org/10.1038/nature25187.
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Contributions
CAO and MNS performed the literature search. JSL performed pathologic interpretations. CAO, MNS, JSL, and MCT drafted, revised, and approve final version of the article for publication.
Corresponding author
Ethics declarations
Conflict of Interest
The authors have no relevant financial or non-financial interests to disclose.
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ortega, C.A., Stevens, M.N., Lewis, J.S. et al. Nasal Mucosal Desmoplastic Melanoma: A Case Report with Review of the Literature. Head and Neck Pathol 16, 942–946 (2022). https://doi.org/10.1007/s12105-022-01429-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-022-01429-6